Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06453928
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-04-26
Brief Title:
Starting Technology in At Risk Type 1 Diabetes Study
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
Starting Technology in At Risk Type 1 Diabetes STAR-T1D Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STAR-T1D
Brief Summary:
Diabetes technology has revolutionized T1D management disparities in technology access are evident among racial-ethnic minorities patients with lower socioeconomic status and those with poorly controlled T1D A1c9 In order to examine whether diabetes technology can reduce diabetes care burdens and enhance outcomes among some of highest need patients diabetes technology clinical trials must be expanded beyond the very select populations included in studies thus far ie mostly White higher SES Therefore the investigators propose to perform a pilot RCT of hybrid closed-loop insulin pump therapy HCL in 40 diverse adult patients with poorly controlled T1D HbA1c 9 from the largest academic and safety net health systems in the Los Angeles region to determine the feasibility of a RCT in this population and identify facilitators and barriers of effective use of closed loop insulin pump therapy in patients with poorly controlled T1D
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5K23DK132482-02 | NIH | None | httpsreporternihgovquickSearch5K23DK132482-02 |